Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVKKB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,699
Award facts
- Contract value 100% obligated
- $76,698.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dupixent 300 mg/2 ml pens with a contract ceiling value of $76,698.63. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, utilizing AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025.
Dupixent (dupilumab) is a prescription biologic medication used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, among other conditions. This delivery order supports the Defense Health Agency and military healthcare systems' pharmaceutical supply needs. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement across the Defense Logistics Agency's medical supply chain, delivering a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies. The DLA is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving as a key supplier for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FVKKB?
SPE2DB25FVKKB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FVKKB worth?
The government has obligated $76,699 on SPE2DB25FVKKB.
Is contract SPE2DB25FVKKB an order under another contract?
Yes. SPE2DB25FVKKB is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVKKB competed?
The extent of competition for SPE2DB25FVKKB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award